Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Frigate Ventures | 3.8M | $5.0M | 0% | Sep 2024 |
|
| Vanguard Group | 1.8M | $2.3M | 7% | Jun 2024 |
|
| Acadian Asset Management | 1.1M | $1.4M | 0% | Sep 2024 |
|
| Renaissance Technologies | 975k | $1.3M | 0% | Sep 2024 |
|
| Alphabet | 890k | $1.2M | 0% | Sep 2024 |
|
| Murchinson | 874k | $1.1M | 0% | Jun 2024 |
|
| Atlas Venture Life Science Advisors | 535k | $696k | -12% | Jun 2024 |
|
| BlackRock | 485k | $650k | 100% | Sep 2024 |
|
| BlackRock | 483k | $628k | 1% | Jun 2024 |
|
| Geode Capital Management | 481k | $645k | -2% | Sep 2024 |
|
| Novo A/S | 469k | $628k | 0% | Sep 2024 |
|
| AWM Investment Company | 333k | $447k | 0% | Sep 2024 |
|
| Bridgeway Capital Management | 185k | $240k | 0% | Jun 2024 |
|
| State Street Corporation | 131k | $170k | 0% | Jun 2024 |
|
| DAFNA Capital Management | 125k | $168k | 0% | Sep 2024 |
|
| Northern Trust | 112k | $149k | -3% | Sep 2024 |
|
| Citadel Advisors | 82k | $110k | -74% | Sep 2024 |
|
| Two Sigma Securities | 68k | $88k | 100% | Jun 2024 |
|
| Susquehanna International | 44k | $59k | 92% | Sep 2024 |
|
| Man Group | 39k | $52k | -48% | Sep 2024 |
|
| Mackenzie Financial | 32k | $43k | -3% | Sep 2024 |
|
| DLK Investment Management | 31k | $42k | 0% | Sep 2024 |
|
| Charles Schwab Investment Management | 29k | $38k | 0% | Sep 2024 |
|
| Shay Capital | 25k | $33k | -92% | Jun 2024 |
|
| Dimensional Fund Advisors | 10k | $13k | 0% | Sep 2024 |
|
| National Bank Of Canada /fi/ | 10k | $13k | 100% | Sep 2024 |
|
| Morgan Stanley | 7.0k | $9.1k | -12% | Jun 2024 |
|
| Russell Investments | 6.4k | $8.3k | 0% | Jun 2024 |
|
| Bank of America Corporation | 5.7k | $7.6k | 2% | Sep 2024 |
|
| Atlantic Trust | 2.9k | $3.9k | 100% | Sep 2024 |
|
| WR Wealth Planners | 2.6k | $3.5k | 0% | Sep 2024 |
|
| Cullen Frost Bankers | 2.0k | $2.7k | 0% | Sep 2024 |
|
| Simplex Trading | 921.00 | $1.0k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 295.00 | $395.005000 | 528% | Sep 2024 |
|
| Tower Research Capital | 276.00 | $358.993200 | 28% | Jun 2024 |
|
| Jpmorgan Chase & Co | 236.00 | $316.004000 | 0% | Sep 2024 |
|
| Wells Fargo & Company | 200.00 | $268.000000 | -80% | Sep 2024 |
|
| CoreCap Advisors | 192.00 | $256.992000 | 0% | Sep 2024 |
|
| Us Bancorp | 151.00 | $201.992700 | 0% | Sep 2024 |
|
| Goss Wealth Management | 100.00 | $130.000000 | 0% | Jun 2024 |
|
| Northwestern Mutual Wealth Management Company | 50.00 | $67.000000 | 100% | Sep 2024 |
|
| Federation des caisses Desjardins du Quebec | 30.00 | $39.999000 | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 12.00 | $15.999600 | 0% | Sep 2024 |
|
| Qube Research & Technologies | 1.00 | $1.000000 | 0% | Jun 2024 |
|
Who sold out of Spero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 99k | $128k |
| Squarepoint Ops | Mar 2024 | 79k | $137k |
| Yale Capital Corp. | Mar 2024 | 10k | $17k |
| Royal Bank of Canada | Jun 2024 | 2.0k | $4.3k |
| IFP Advisors | Mar 2024 | 650.00 | $1.1k |
| Hanson McClain Advisors | Jun 2024 | 600.00 | $840.000000 |
| Rhumbline Advisers | Jun 2024 | 458.00 | $594.987800 |